1. Home
  2. MXL vs QURE Comparison

MXL vs QURE Comparison

Compare MXL & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$17.84

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$10.94

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXL
QURE
Founded
2003
1998
Country
United States
Netherlands
Employees
N/A
248
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2009
2013

Fundamental Metrics

Financial Performance
Metric
MXL
QURE
Price
$17.84
$10.94
Analyst Decision
Buy
Buy
Analyst Count
5
14
Target Price
$19.80
$56.25
AVG Volume (30 Days)
998.2K
2.5M
Earning Date
04-29-2026
06-02-2026
Dividend Yield
N/A
N/A
EPS Growth
46.08
29.67
EPS
N/A
N/A
Revenue
$478,596,000.00
$13,107,000.00
Revenue This Year
$22.10
N/A
Revenue Next Year
$10.70
$142.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.40
$7.76
52 Week High
$20.82
$71.50

Technical Indicators

Market Signals
Indicator
MXL
QURE
Relative Strength Index (RSI) 47.13 25.96
Support Level $17.90 N/A
Resistance Level $18.44 $16.62
Average True Range (ATR) 0.95 2.17
MACD -0.13 -1.21
Stochastic Oscillator 30.28 9.27

Price Performance

Historical Comparison
MXL
QURE

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: